Efficacy and Tolerability of Osimertinib and Sotorasib Combination Treatment for Osimertinib Resistance Caused by <i>KRAS</i> G12C Mutation: A Report of Two Cases.

Ernst, Sophie M; Uzun, Sevim; Paats, Marthe S; van Marion, Ronald; Atmodimedjo, Peggy N; de Jonge, Evert; van Schaik, Ron H N; Aerts, Joachim G J V; von der Thüsen, Jan H; Dubbink, Hendrikus J; Dingemans, Anne-Marie C

Efficacy and Tolerability of Osimertinib and Sotorasib Combination Treatment for Osimertinib Resistance Caused by KRAS G12C Mutation: A Report of Two Cases.

Ernst, Sophie M; Uzun, Sevim; Paats, Marthe S; van Marion, Ronald; Atmodimedjo, Peggy N; de Jonge, Evert; van Schaik, Ron H N; Aerts, Joachim G J V; von der Thüsen, Jan H; Dubbink, Hendrikus J; Dingemans, Anne-Marie C.

Afiliación

Ernst SM; Department of Respiratory Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
Uzun S; Department of Respiratory Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
Paats MS; Department of Respiratory Medicine, Haaglanden Medisch Centrum, Den Haag, the Netherlands.
van Marion R; Department of Respiratory Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
Atmodimedjo PN; Department of Pathology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
de Jonge E; Department of Pathology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
van Schaik RHN; Department of Clinical Chemistry, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Aerts JGJV; Department of Clinical Chemistry, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
von der Thüsen JH; Department of Respiratory Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
Dubbink HJ; Department of Pathology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Dingemans AC; Department of Pathology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.

JCO Precis Oncol ; 7: e2300451, 2023 Sep.

Article en En | MEDLINE | ID: mdl-38096473

Asunto(s)

Proteínas Proto-Oncogénicas p21(ras); Humanos; Proteínas Proto-Oncogénicas p21(ras)/genética; Mutación

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas p21(ras) Límite: Humans Idioma: En Revista: JCO Precis Oncol Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google